Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Highest Profit Margin

Below are the top diagnostic substances stocks on the NASDAQ in terms of profit margin.

The trailing-twelve-month profit margin at Trinity Biotech plc (NASDAQ: TRIB) is 20.40%. Trinity Biotech's revenue for the same period is $82.97 million.

The trailing-twelve-month profit margin at Meridian Bioscience (NASDAQ: VIVO) is 20.35%. Meridian Bioscience's ROE for the same period is 25.63%.

The trailing-twelve-month profit margin at Abaxis (NASDAQ: ABAX) is 14.87%. Abaxis's PEG ratio is 2.96.

The trailing-twelve-month profit margin at IDEXX Laboratories (NASDAQ: IDXX) is 14.02%. IDEXX Laboratories had $251.01 million in total cash for the latest quarter.